HJLI specializes in developing and manufacturing bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has three product candidates: the porcine tissue based VenoValve®, which is intended to be surgically implanted in the deep venous system of the leg to treat Chronic Venue Insufficiency; the CoreoGraft®, a bovine tissue based off the shelf conduit intended to be used for coronary artery bypass surgery, and a porcine tissue based heart valve, which based upon its relatively small size and increased output, is an ideal candidate for pediatric aortic/mitral valve replacement.
Stock Information
Company Overview
Investor Contact Information
Company
Hancock Jaffe Laboratories, Inc.
70 Doppler
Irvine, CA 92618
T: 949-261-2900
F: 949-261-2992
Investor Relations
Robert A Berman
CEO
T: 949 261-2900
Transfer Agent
V Stock Transfer LLC